Article Versions Notes

Marking U, Havervall S, Greilert-Norin N, Ng H, Blom K, Nilsson P, Phillipson M, Hober S, Nilsson C, Mangsbo S, et al. Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. Vaccines. 2022; 10(3):359. https://doi.org/10.3390/vaccines10030359

Marking, Ulrika, Sebastian Havervall, Nina Greilert-Norin, Henry Ng, Kim Blom, Peter Nilsson, Mia Phillipson, Sophia Hober, Charlotta Nilsson, Sara Mangsbo, and et al. 2022. "Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines" Vaccines 10, no. 3: 359. https://doi.org/10.3390/vaccines10030359

Marking, U., Havervall, S., Greilert-Norin, N., Ng, H., Blom, K., Nilsson, P., Phillipson, M., Hober, S., Nilsson, C., Mangsbo, S., Christ, W., Klingström, J., Gordon, M., Åberg, M., & Thålin, C. (2022). Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. Vaccines, 10(3), 359. https://doi.org/10.3390/vaccines10030359